Literature DB >> 4042087

Regression models for prognostic prediction: advantages, problems, and suggested solutions.

F E Harrell, K L Lee, D B Matchar, T A Reichert.   

Abstract

Multiple regression models have wide applicability in predicting the outcome of patients with a variety of diseases. However, many researchers are using such models without validating the necessary assumptions. All too frequently, researchers also "overfit" the data by developing models using too many predictor variables and insufficient sample sizes. Models developed in this way are unlikely to stand the test of validation on a separate patient sample. Without attempting such a validation, the researcher remains unaware that overfitting has occurred. When the ratio of the number of patients suffering endpoints to the number of potential predictors is small (say less than 10), data reduction methods are available that can greatly improve the performance of regression models. Regression models can make more accurate predictions than other methods such as stratification and recursive partitioning, when model assumptions are thoroughly examined; steps are taken (ie, choosing another model or transforming the data) when assumptions are violated; and the method of model formulation does not result in overfitting the data.

Entities:  

Mesh:

Year:  1985        PMID: 4042087

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  112 in total

1.  Artificial intelligence for clinicians.

Authors:  P J Drew; J R Monson
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Statistical analysis of medical data. Part III: multivariable analysis.

Authors:  R Hachamovitch; C Shufelt
Journal:  J Nucl Cardiol       Date:  2000 Sep-Oct       Impact factor: 5.952

3.  From monitoring to predicting outcome.

Authors:  J G Reves; L R Smith
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

4.  Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  BMC Med       Date:  2012-05-29       Impact factor: 8.775

5.  Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Authors:  Douglas G Altman; Lisa M McShane; Willi Sauerbrei; Sheila E Taube
Journal:  PLoS Med       Date:  2012-05-29       Impact factor: 11.069

6.  External validity of risk models: Use of benchmark values to disentangle a case-mix effect from incorrect coefficients.

Authors:  Yvonne Vergouwe; Karel G M Moons; Ewout W Steyerberg
Journal:  Am J Epidemiol       Date:  2010-08-31       Impact factor: 4.897

7.  Comparing clinical outcomes for a twelve-month trial of zotarolimus- and everolimus-eluting stents in patients with coronary artery disease: data from the THCRIC registry.

Authors:  Hamid Reza Poorhoseini; Seyed Ebrahim Kassaian; Kianoosh Hoseini; Sepideh Saroukhani; Mojtaba Salarifar; Mohammad Alidoosti; Ebrahim Nematipour; Ali Mohammad Haji-Zeinali; Alireza Amirzadegan; Mir Hossein Seyyed Mohammadzadeh; Kamal Khadem Vatan; Hassan Aghajani; Mahmood Sheikh Fathollahi; Hamidreza Farrokh-Eslamlou
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-02-07

8.  B-type natriuretic peptide and weaning from mechanical ventilation.

Authors:  Armand Mekontso-Dessap; Nicolas de Prost; Emmanuelle Girou; François Braconnier; François Lemaire; Christian Brun-Buisson; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-08-29       Impact factor: 17.440

Review 9.  Applicability and relevance of models that predict short term outcome after intracerebral haemorrhage.

Authors:  M J Ariesen; A Algra; H B van der Worp; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-06       Impact factor: 10.154

10.  Controlling tuberculosis in an urban emergency department: a rapid decision instrument for patient isolation.

Authors:  J T Redd; E Susser
Journal:  Am J Public Health       Date:  1997-09       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.